Maximum Dosing for Loperamide and Bismuth Subsalicylate
The maximum daily dose of loperamide is 16 mg per day, and for bismuth subsalicylate (Pepto-Bismol) is 4.2-4.9 grams per day.
Loperamide Maximum Dosing
For loperamide, the FDA-approved maximum is 16 mg (eight 2-mg capsules) in a 24-hour period 1. This applies to both acute and chronic diarrhea management in adults and pediatric patients 13 years and older.
Dosing Algorithm for Loperamide:
- Initial dose: 4 mg (two capsules)
- Maintenance: 2 mg after each unformed stool
- Daily maximum: 16 mg (do not exceed) 2, 1
Multiple high-quality guidelines consistently cite this 16 mg maximum 2, 3. The ESMO 2018 guidelines specifically state: "Loperamide can be started at an initial dose of 4 mg followed by 2 mg every 2-4 h or after every unformed stool. The maximum daily dose of loperamide is 16 mg" 2.
Critical Safety Warning:
Exceeding 16 mg daily carries serious cardiac risks, including QT prolongation, Torsades de Pointes, ventricular arrhythmias, cardiac arrest, and death 1. The FDA has issued explicit warnings about supratherapeutic dosing. Cases of severe cardiotoxicity have been reported with chronic doses ranging from 70-1600 mg daily 1. Recent systematic reviews show severe toxicity can occur at doses as low as 20-40 mg/day, with a median severe toxicity dose (TD50) of 85 mg 4.
Never recommend or use higher doses, even in refractory cases. If 16 mg/day fails to control diarrhea after 48 hours, escalate to alternative agents (octreotide, antibiotics if indicated) rather than increasing loperamide 2.
Bismuth Subsalicylate Maximum Dosing
The maximum daily dose of bismuth subsalicylate is 4.2-4.9 grams per day 5, 6. This translates to approximately 8 doses of the standard 524 mg formulation (Pepto-Bismol).
Key Dosing Details:
- Standard formulation: 524 mg per dose
- Maximum: 4.2-4.9 g/day (approximately 8 doses)
- Duration: Safe for acute use and up to 3-4 weeks of extended dosing 6
The salicylate component is extensively absorbed (>90%), but at maximal daily doses of 4.2 g, peak plasma salicylate concentrations remain well below toxic levels 6. Bismuth absorption is minimal (<0.005%), with extended dosing producing blood bismuth levels far below neurotoxicity thresholds 6.
Comparative Efficacy Note
While both agents are effective, loperamide provides faster and more complete relief than bismuth subsalicylate at these maximum doses. In head-to-head comparison, loperamide 8 mg/day significantly reduced unformed stools and provided better subjective relief than bismuth subsalicylate 4.9 g/day 5. However, bismuth subsalicylate has documented efficacy for both prevention and treatment of infectious diarrhea, with meta-analyses showing 3.7 times greater odds of symptomatic improvement versus placebo 7.
Pediatric Considerations
For children 2-12 years, loperamide dosing is weight-based with lower maximums 1:
- Ages 2-5 (≤20 kg): 3 mg total daily maximum
- Ages 6-8 (20-30 kg): 4 mg total daily maximum
- Ages 8-12 (>30 kg): 6 mg total daily maximum
Loperamide is contraindicated in children under 2 years due to risks of respiratory depression and cardiac adverse reactions 1.